Nakao K - Search Results

1

Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis.

Miuma S, Miyaaki H, Taura N, Kanda Y, Matsuo S, Tajima K, Takahashi K, Nakao Y, Fukushima M, Haraguchi M, Sasaki R, Ozawa E, Ichikawa T, Nakao K. Miuma S, et al. Among authors: nakao k, nakao y. Sci Rep. 2024 Oct 23;14(1):25003. doi: 10.1038/s41598-024-76040-6. Sci Rep. 2024. PMID: 39443545 Free PMC article.

2

Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.

Arima T, Nakao K, Nakata K, Ishikawa H, Ichikawa T, Hamasaki K, Ishii N, Eguchi K. Arima T, et al. Among authors: nakao k. Int J Mol Med. 2002 Apr;9(4):397-400. Int J Mol Med. 2002. PMID: 11891535

3

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.

Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, Ishikawa H, Ishii N, Eguchi K. Ichikawa T, et al. Among authors: nakao k. Biochem Biophys Res Commun. 2002 Jun 7;294(2):414-22. doi: 10.1016/S0006-291X(02)00502-8. Biochem Biophys Res Commun. 2002. PMID: 12051728

4

Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults.

Nakao K, Nakata K, Ohtsubo N, Maeda M, Moriuchi T, Ichikawa T, Hamasaki K, Kato Y, Eguchi K, Yukawa K, Ishii N. Nakao K, et al. Am J Gastroenterol. 2002 Jul;97(7):1796-801. doi: 10.1111/j.1572-0241.2002.05846.x. Am J Gastroenterol. 2002. PMID: 12135038

5

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K. Ohkubo K, et al. Among authors: nakao k. Cancer. 2002 May 15;94(10):2663-8. doi: 10.1002/cncr.10557. Cancer. 2002. PMID: 12173334 Free article.

6

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells.

Tamada Y, Nakao K, Nagayama Y, Nakata K, Ichikawa T, Kawamata Y, Ishikawa H, Hamasaki K, Eguchi K, Ishii N. Tamada Y, et al. Among authors: nakao k. J Hepatol. 2002 Oct;37(4):493-9. doi: 10.1016/s0168-8278(02)00232-5. J Hepatol. 2002. PMID: 12217603

7

Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.

Yanagi K, Nagayama Y, Nakao K, Saeki A, Matsumoto K, Ichikawa T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Yanagi K, et al. Among authors: nakao k. Int J Oncol. 2003 Feb;22(2):345-51. Int J Oncol. 2003. PMID: 12527933

8

Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.

Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K. Ishikawa H, et al. Among authors: nakao k. Hepatology. 2003 Mar;37(3):696-704. doi: 10.1053/jhep.2003.50077. Hepatology. 2003. PMID: 12601367

9

Short interfering RNA-directed inhibition of hepatitis B virus replication.

Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Hamasaki K, et al. Among authors: nakao k. FEBS Lett. 2003 May 22;543(1-3):51-4. doi: 10.1016/s0014-5793(03)00400-9. FEBS Lett. 2003. PMID: 12753904 Free article.

10

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. Ohata K, et al. Among authors: nakao k. Cancer. 2003 Jun 15;97(12):3036-43. doi: 10.1002/cncr.11427. Cancer. 2003. PMID: 12784339 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,314 results

Search Page

Filters